Search research articles
Contact Us
Filters
Showing results (251-260 of 294) with videos related to
Page
of 30
Sort By:
Blood Advances
|
April 9, 2025
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential
Miriam Verdú-Bou, Maria Joao Baptista, Marcelo Lima Ribeiro, et al.
JAMA Oncology
|
February 9, 2023
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial
Martin Bornhäuser, Christoph Schliemann, Johannes Schetelig, et al.
Leukemia
|
August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
Sabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Blood Cancer Journal
|
June 2, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis
Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, et al.
Journal of Hematology & Oncology
|
December 2, 2022
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia
Nicole Bäumer, Annika Scheller, Lisa Wittmann, et al.
Hemasphere
|
August 20, 2025
Efficacy of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma and prior central nervous system manifestation: A multicenter real-world analysis
Markus Maulhardt, Simon Call, Hristo Boyadzhiev, et al.
Cancers
|
June 11, 2020
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
Christoph Schliemann, Mirjam Gerwing, Hauke Heinzow, et al.
Leukemia
|
March 29, 2018
The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
Nikolai Schleussner, Olaf Merkel, Mariantonia Costanza, et al.
Blood
|
January 15, 2025
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia
Julian Ronnacker, Michael Grau, Maximilian Klasmeier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2009
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy
William W L Choi, Dennis D Weisenburger, Timothy C Greiner, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 294) with videos related to
Sort By:
Page
of 30
Blood Advances
|
April 9, 2025
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential
Miriam Verdú-Bou, Maria Joao Baptista, Marcelo Lima Ribeiro, et al.
JAMA Oncology
|
February 9, 2023
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial
Martin Bornhäuser, Christoph Schliemann, Johannes Schetelig, et al.
Leukemia
|
August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
Sabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Blood Cancer Journal
|
June 2, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis
Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, et al.
Journal of Hematology & Oncology
|
December 2, 2022
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia
Nicole Bäumer, Annika Scheller, Lisa Wittmann, et al.
Hemasphere
|
August 20, 2025
Efficacy of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma and prior central nervous system manifestation: A multicenter real-world analysis
Markus Maulhardt, Simon Call, Hristo Boyadzhiev, et al.
Cancers
|
June 11, 2020
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
Christoph Schliemann, Mirjam Gerwing, Hauke Heinzow, et al.
Leukemia
|
March 29, 2018
The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
Nikolai Schleussner, Olaf Merkel, Mariantonia Costanza, et al.
Blood
|
January 15, 2025
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia
Julian Ronnacker, Michael Grau, Maximilian Klasmeier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2009
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy
William W L Choi, Dennis D Weisenburger, Timothy C Greiner, et al.
Page
of 30